KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
88 hedge funds and large institutions have $35.2M invested in Chinook Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
-9
Holders Change %
-9.28%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
26
Reduced
30
Closed
18
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$65K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.07M |
| 2 |
Renaissance Technologies
New York
|
+$981K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$570K |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$205K |
| 5 |
D.E. Shaw & Co
New York
|
+$204K |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.71M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.19M |
| 3 |
ClearBridge Investments
New York
|
-$341K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$304K |
| 5 |
Goldman Sachs
New York
|
-$225K |
